Innospec Inc. Files Definitive Proxy Statement for Annual Meeting

Ticker: IOSP · Form: DEF 14A · Filed: Mar 28, 2024 · CIK: 1054905

Sentiment: neutral

Topics: Proxy Statement, Annual Meeting, DEF 14A, Innospec Inc., Shareholder Voting

TL;DR

<b>Innospec Inc. has filed its Definitive Proxy Statement for the upcoming Annual Meeting of Stockholders.</b>

AI Summary

INNOSPEC INC. (IOSP) filed a Proxy Statement (DEF 14A) with the SEC on March 28, 2024. Innospec Inc. filed a Definitive Proxy Statement (DEF 14A) on March 28, 2024. The filing pertains to the Annual Meeting of Stockholders, with a report period ending May 10, 2024. The company's principal executive offices are located in Englewood, Colorado. Innospec Inc. was formerly known as Octel Corp, with a name change date of February 9, 1998. The filing indicates no fee was required for this filing, as it was paid previously or is not applicable.

Why It Matters

For investors and stakeholders tracking INNOSPEC INC., this filing contains several important signals. This filing provides shareholders with essential information regarding the upcoming annual meeting, including details on voting procedures and matters to be discussed. As a DEF 14A filing, it signifies the final version of the proxy materials being distributed to shareholders for their consideration and voting.

Risk Assessment

Risk Level: low — INNOSPEC INC. shows low risk based on this filing. The filing is a routine proxy statement (DEF 14A) and does not contain new financial performance data or strategic shifts that would indicate immediate high risk.

Analyst Insight

Review the proxy statement to understand the agenda for the Annual Meeting of Stockholders and any proposals requiring shareholder votes.

Key Numbers

Key Players & Entities

FAQ

When did INNOSPEC INC. file this DEF 14A?

INNOSPEC INC. filed this Proxy Statement (DEF 14A) with the SEC on March 28, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by INNOSPEC INC. (IOSP).

Where can I read the original DEF 14A filing from INNOSPEC INC.?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by INNOSPEC INC..

What are the key takeaways from INNOSPEC INC.'s DEF 14A?

INNOSPEC INC. filed this DEF 14A on March 28, 2024. Key takeaways: Innospec Inc. filed a Definitive Proxy Statement (DEF 14A) on March 28, 2024.. The filing pertains to the Annual Meeting of Stockholders, with a report period ending May 10, 2024.. The company's principal executive offices are located in Englewood, Colorado..

Is INNOSPEC INC. a risky investment based on this filing?

Based on this DEF 14A, INNOSPEC INC. presents a relatively low-risk profile. The filing is a routine proxy statement (DEF 14A) and does not contain new financial performance data or strategic shifts that would indicate immediate high risk.

What should investors do after reading INNOSPEC INC.'s DEF 14A?

Review the proxy statement to understand the agenda for the Annual Meeting of Stockholders and any proposals requiring shareholder votes. The overall sentiment from this filing is neutral.

How does INNOSPEC INC. compare to its industry peers?

Innospec Inc. operates in the chemicals sector, providing specialty chemicals for various industrial applications.

Are there regulatory concerns for INNOSPEC INC.?

This filing is a standard regulatory requirement under the Securities Exchange Act of 1934, specifically Section 14(a), concerning proxy solicitations.

Industry Context

Innospec Inc. operates in the chemicals sector, providing specialty chemicals for various industrial applications.

Regulatory Implications

This filing is a standard regulatory requirement under the Securities Exchange Act of 1934, specifically Section 14(a), concerning proxy solicitations.

What Investors Should Do

  1. Review the agenda items for the Annual Meeting of Stockholders.
  2. Understand any proposals or director nominations presented for shareholder vote.
  3. Note the filing date and report period for context on the proxy statement's relevance.

Year-Over-Year Comparison

This is a DEF 14A filing, which is a definitive proxy statement, indicating it's the final version being sent to shareholders for the annual meeting.

Filing Stats: 4,566 words · 18 min read · ~15 pages · Grade level 14 · Accepted 2024-03-28 06:14:18

Filing Documents

From the Filing

innospec-def14a_051024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 INNOSPEC INC. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required Fee paid previously with preliminary materials Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 2024 NOTICE OF ANNUAL MEETING OF STOCKHOLDERS AND PROXY STATEMENT INNOSPEC INC. 8310 South Valley Highway, Suite 350, Englewood, CO 80112 NOTICE OF 2024 ANNUAL MEETING OF STOCKHOLDERS Date and time Friday, May 10, 2024, 10:00 a.m. Eastern Time Location The offices of Smith, Gambrell & Russell LLP, 1105 West Peachtree Street NE Suite 1000 Atlanta, GA 3030 9 Record Date March 15, 2024 Proposals Proposal 1 Election of two Class II Directors Proposal 2 Advisory approval of the Company's executive compensation Proposal 3 Ratification of the appointment of the Company's independent registered public accounting firm To obtain Prox y Mate rials www.envisionreports.com/iosp (for stockholders of record) www.edocumentview.com/iosp (for beneficial owners with shares held in "street name") Call 1-866-641-4276 (for stockholders of record) Call 1-800-579-1639 (for beneficial owners with shares held in "str eet name") investorvote@computershare.com with "Proxy Materials Innospec Inc." in the subject line (f or stockh olders of record) sendmaterial@proxyvote.com (for beneficial owners with shares held in "street name") Voting Methods www.envisionreports.com/iosp (for stockholders of record) www.proxyvote.com (for beneficial owners with shares held in "street name") Call the toll-free number 1-800-652-8683 (Beneficial owners with shares held in "street name" should contact their bank or broker) Complete and return a proxy card (if you received a paper copy) Attend and vote at the Annual Meeting Stockholders may also transact any other business properly brought before the meeting. At this time, the Board of Directors knows of no other proposals or matters to be presented. On behalf of the Board of Directors: David B. Jones Senior Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary March 26, 2024 TABLE OF CONTENTS Page No. INFORMATION ABOUT THE 2024 ANNUAL MEETING OF STOCKHOLDERS AND VOTING AT THE MEETING 1 CORPORATE GOVERNANCE 7 Corporate Governance Highlights 7 Our Corporate Governance Framework 7 Corporate Governance Principles 7 Corporate Governance Guidelines 8 Innospec's Leadership Structure 8 The Board's Role in Risk Management 9 Director Independence 12 Family Relationships 12 Related Person Transactions and Relationships 12 Related Person Transactions Approval Policy 13 Executive Sessions of Independent Non-Management Directors 13 Identifying and Evaluating Nominees for Director 13 Director On-Boarding and Continuing Education 15 Meetings and Attendance 15 Limitation on Other Board and Audit Committee Positions 15 Code of Conduct 16 Supplier Code of Conduct 16 Raising Issues and Reporting Violations 17 No Retaliation on Reporting Issues or Violations 17 Anti-Hedging Policy 17 Anti-Pledging Policy 17 Copies of Code of Conduct, Corporate Governance Guidelines and Committee Charters 17 Communications with our Board 18 Board Committees 18 Board and Committee Self-Evaluations 22 Stockholder Engagement 22 ENVIRONMENTAL, SOCIAL AND GOVERNANCE 23 HUMAN CAPITAL MANAGEMENT 30 PROPOSAL 1: ELECTION OF TWO CLASS II DIRECTORS 33 INFORMATION ABOUT THE INNOSPEC BOARD 35 Board Skills Matrix 35 Board Diversity Matrix 37 Director Biographies 37 DIRECTOR COMPENSATION 43 Elements of Director Compensation 43 Director Stock Ownership Guidelines 44 Director Compensation For Fiscal 2023 44 WHO OWNS OUR STOCK? INFORMATION ABOUT OUR COMMON STOCK OWNERSHIP 47 Stock Ownership of Directors and Executive Officers as of February 15, 2024 47 Beneficial Owners as at Fiscal Year End 2023 48 Delinquent Section 16(a) Reports 48 Equity Compensation Plans 49 PROPOSAL 2: ADVISORY APPROVAL OF INNOSPEC'S EXECUTIVE COMPENSATION 50 PROPOSAL 3: RATIFICATION OF THE APPOINTMENT OF THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 51 Principal Accountant Fees and Services 51 Audit Comm

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing